Butantan Institute
Clinical trials sponsored by Butantan Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Dengue vaccine trial aims to protect seniors Results expected Mar 2027 (estimated)
- One shot, two protections? new trial combines dengue and chikungunya vaccines Results expected Jul 2027 (estimated)
- New H5N8 bird flu vaccine enters human trials Results expected Aug 2027 (estimated)
-
Dengue vaccine trial aims to protect seniors
Vaccine Recruiting nowThis study tests a dengue vaccine in adults aged 60 to 79 and compares their immune response and safety to adults aged 40 to 59. About 997 healthy participants will receive one dose of the Butantan dengue vaccine. The goal is to see if the vaccine works as well in older adults as…
Phase 3 • Sponsor: Butantan Institute • Aim: Vaccine
Last updated Jul 18, 2026 00:00 UTC
-
New H5N8 bird flu vaccine enters human trials
Vaccine Recruiting nowThis study tests two doses of an experimental H5N8 avian flu vaccine in 700 healthy adults and older adults. The vaccine is inactivated and contains an adjuvant to boost immunity. Researchers will monitor side effects and measure antibody levels to see if the vaccine triggers a p…
Phase 1/2 • Sponsor: Butantan Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:03 UTC